<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01926119</url>
  </required_header>
  <id_info>
    <org_study_id>25894</org_study_id>
    <nct_id>NCT01926119</nct_id>
  </id_info>
  <brief_title>TMS for CRPS - Pilot Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to test whether Transcranial Magnetic Stimulation (TMS)
      may alleviate the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will
      test various methods of TMS in a small pilot study to investigate what methods may have
      clinical potential. This is a small pilot study to determine feasibility and signal to
      potentially inform future trials.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain</measure>
    <time_frame>Baseline to post-TMS day 5</time_frame>
    <description>Numerical rating scale (NRS) where 0=no pain and 10=worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Motor Function and Coordination</measure>
    <time_frame>End of 5-day treatment series and at 1-week follow-up relative to baseline</time_frame>
    <description>As assessed by functional capacity exam and physical exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Sensory Perception</measure>
    <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vasomotor Function</measure>
    <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Sudomotor Function</measure>
    <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trophic Changes</measure>
    <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Motor Strength and Joint Range of Motion</measure>
    <time_frame>End of each of the 5 treatment sessions and at 1-week follow-up relative to baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Complex Regional Pain Syndrome (CRPS)</condition>
  <arm_group>
    <arm_group_label>TMS Intervention - 5 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <arm_group_label>TMS Intervention - 5 days</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 or older

          2. Diagnosis of CRPS (complex regional pain syndrome)

          3. Average pain level reported on Numerical Rating Scale meets entry criteria

          4. Ability to perform the experimental task and procedures.

        Exclusion Criteria:

          1. MRI contraindication (metal implants or devices, claustrophobia)

          2. TMS Contraindication (eg metal implant or devices near the site of stimulation)

          3. History of epilepsy

          4. History of a psychological or psychiatric disorder that would interfere with study
             procedures, at the discretion of the researcher.

          5. Neurologic illness that would interfere with brain integrity

          6. Current medical condition or medication use that would interfere with study procedures
             or data integrity, at the discretion of the researcher.

          7. Currently pregnant or planning to become pregnant.

          8. On going legal action or disability claim.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2013</study_first_submitted>
  <study_first_submitted_qc>August 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2013</study_first_posted>
  <results_first_submitted>November 17, 2015</results_first_submitted>
  <results_first_submitted_qc>March 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2017</results_first_posted>
  <last_update_submitted>March 30, 2017</last_update_submitted>
  <last_update_submitted_qc>March 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Sean Mackey</investigator_full_name>
    <investigator_title>Chief, Division of Pain Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>TMS Intervention - 5 Days</title>
          <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days in the order of Theta Burst Stimulation followed by High frequency stimulation
Transcranial Magnetic Stimulation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>TMS Intervention - 5 Days</title>
          <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days in the order of Theta Burst Stimulation followed by High frequency stimulation
Transcranial Magnetic Stimulation</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.5" lower_limit="48" upper_limit="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Pain</title>
        <description>Numerical rating scale (NRS) where 0=no pain and 10=worst pain imaginable</description>
        <time_frame>Baseline to post-TMS day 5</time_frame>
        <population>Completed 5 days of TMS</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pain</title>
          <description>Numerical rating scale (NRS) where 0=no pain and 10=worst pain imaginable</description>
          <population>Completed 5 days of TMS</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline NRS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="3.6" upper_limit="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-TMS day 5 NRS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" lower_limit="0" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Motor Function and Coordination</title>
        <description>As assessed by functional capacity exam and physical exam</description>
        <time_frame>End of 5-day treatment series and at 1-week follow-up relative to baseline</time_frame>
        <population>This data was not collected and was therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Motor Function and Coordination</title>
          <description>As assessed by functional capacity exam and physical exam</description>
          <population>This data was not collected and was therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Sensory Perception</title>
        <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
        <population>This data was not collected and therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sensory Perception</title>
          <population>This data was not collected and therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Vasomotor Function</title>
        <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
        <population>This data was not collected and therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Vasomotor Function</title>
          <population>This data was not collected and therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Sudomotor Function</title>
        <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
        <population>This data was not collected and therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sudomotor Function</title>
          <population>This data was not collected and therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Trophic Changes</title>
        <time_frame>End of each treatment session and at 1-week follow-up as compared to baseline</time_frame>
        <population>This data was not collected and therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Trophic Changes</title>
          <population>This data was not collected and therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Motor Strength and Joint Range of Motion</title>
        <time_frame>End of each of the 5 treatment sessions and at 1-week follow-up relative to baseline</time_frame>
        <population>This data was not collected and therefore not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>TMS Intervention - 5 Days</title>
            <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Transcranial Magnetic Stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Motor Strength and Joint Range of Motion</title>
          <population>This data was not collected and therefore not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were followed during 5 days of treatment and for 1 week following treatment</time_frame>
      <desc>Participants were assessed for pain before and after each treatment session and at 1 week follow-up. During these assessments adverse events were evaluated as well.</desc>
      <group_list>
        <group group_id="E1">
          <title>TMS Intervention - 5 Days</title>
          <description>Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days in the order of Theta Burst Stimulation followed by High frequency stimulation
Transcranial Magnetic Stimulation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea and vomiting</sub_title>
                <description>participants reported nausea and vomiting 6-8 hours after treatment</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>participants reported headache after stimulation</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kevin Johnson, PhD RN</name_or_title>
      <organization>Stanford University</organization>
      <phone>(650) 721-1988</phone>
      <email>johnsk@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

